TPWA
ROIV icon

Twin Peaks Wealth Advisors’s Roivant Sciences ROIV Stock Holding History

Twin Peaks Wealth Advisors’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-257
Closed -$7.12K – 1769
2026
Q1 		$7.12K Buy
+257
New +$6.6K ﹤0.01% 1234
2025
Q3 		– Sell
-180
Closed -$2.08K – 1679
2025
Q2 		$2.08K Buy
+180
New +$1.95K ﹤0.01% 1612

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Twin Peaks Wealth Advisors's ROIV Position: Q2 2026 in Review

Twin Peaks Wealth Advisors sold out of Roivant Sciences (ROIV) in Q2 2026, closing a stake of 257 shares — an estimated $7.12K sold.

Twin Peaks Wealth Advisors first reported a position in ROIV in Q2 2025 and held it in 2 quarters. The position peaked at $7.12K in Q1 2026. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Twin Peaks Wealth Advisors reported no remaining Roivant Sciences position as of Q2 2026 after selling out during the quarter.
  • Twin Peaks Wealth Advisors sold 257 Roivant Sciences shares in Q2 2026, an estimated $7.12K.
  • Twin Peaks Wealth Advisors first reported a position in Roivant Sciences in Q2 2025 and held it in 2 quarters.
  • Twin Peaks Wealth Advisors's Roivant Sciences position peaked at $7.12K in Q1 2026.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Twin Peaks Wealth Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.